BACKGROUND: Cognitive impairment may occur at any time during the course of multiple sclerosis (MS), and it is often a major cause of disability in patients with the disease. The APOE-epsilon4 allele is the major known genetic risk factor for late onset familial and sporadic Alzheimer's Disease (AD), and it seems to be implicated in cognitive decline in normal elderly persons. OBJECTIVE: To investigate the clinical and genetic variables that can be associated with the cognitive decline in patients with MS. METHODS: Five-hundred and three patients with clinically definite MS underwent a battery of neuropsychological tests and, according to the number of failed tests, were divided into cognitively normal and impaired. All patients were genotyped for APOE gene polymorphisms. RESULTS: Fifty-six percent of MS patients showed, to different extents, cognitive impairment. Cognitive decline was predominant in men and was associated with disease duration, Kurtzke Expanded Disability Status Scale (EDSS) score, a low level of education, and, interestingly, the epsilon4 allele of the APOE gene. By contrast, cognitive impairment in women was independent of any investigated variable. CONCLUSION: The findings demonstrate that clinical and genetic factors play a role in men affected by MS developing cognitive impairment.
BACKGROUND:Cognitive impairment may occur at any time during the course of multiple sclerosis (MS), and it is often a major cause of disability in patients with the disease. The APOE-epsilon4 allele is the major known genetic risk factor for late onset familial and sporadic Alzheimer's Disease (AD), and it seems to be implicated in cognitive decline in normal elderly persons. OBJECTIVE: To investigate the clinical and genetic variables that can be associated with the cognitive decline in patients with MS. METHODS: Five-hundred and three patients with clinically definite MS underwent a battery of neuropsychological tests and, according to the number of failed tests, were divided into cognitively normal and impaired. All patients were genotyped for APOE gene polymorphisms. RESULTS: Fifty-six percent of MS patients showed, to different extents, cognitive impairment. Cognitive decline was predominant in men and was associated with disease duration, Kurtzke Expanded Disability Status Scale (EDSS) score, a low level of education, and, interestingly, the epsilon4 allele of the APOE gene. By contrast, cognitive impairment in women was independent of any investigated variable. CONCLUSION: The findings demonstrate that clinical and genetic factors play a role in men affected by MS developing cognitive impairment.
Authors: R L Oliveri; R Cittadella; G Sibilia; I Manna; P Valentino; A Gambardella; U Aguglia; M Zappia; N Romeo; V Andreoli; F Bono; M Caracciolo; A Quattrone Journal: Acta Neurol Scand Date: 1999-11 Impact factor: 3.209
Authors: F Fazekas; S Strasser-Fuchs; H Kollegger; T Berger; W Kristoferitsch; H Schmidt; C Enzinger; M Schiefermeier; C Schwarz; B Kornek; M Reindl; K Huber; R Grass; G Wimmer; K Vass; K H Pfeiffer; H P Hartung; R Schmidt Journal: Neurology Date: 2001-09-11 Impact factor: 9.910
Authors: M J Ignatius; P J Gebicke-Härter; J H Skene; J W Schilling; K H Weisgraber; R W Mahley; E M Shooter Journal: Proc Natl Acad Sci U S A Date: 1986-02 Impact factor: 11.205
Authors: G Comi; M Filippi; V Martinelli; G Sirabian; A Visciani; A Campi; S Mammi; M Rovaris; N Canal Journal: J Neurol Sci Date: 1993-04 Impact factor: 3.181
Authors: Eldar Eftekhari; Seyed-Parsa Hojjat; Rita Vitorino; Timothy J Carroll; Charles Grady Cantrell; Liesly Lee; Matthew W Taylor; Sarah A Morrow; Haddas Benhabib; Richard I Aviv; Andrea Kassner Journal: Neuroradiology Date: 2017-06-16 Impact factor: 2.804
Authors: Sienmi Du; Noriko Itoh; Sahar Askarinam; Haley Hill; Arthur P Arnold; Rhonda R Voskuhl Journal: Proc Natl Acad Sci U S A Date: 2014-02-03 Impact factor: 11.205